Are alpha blockers effective in the treatment of bladder elimination problems in female patients with Multiple Sclerosis?

Stopped earlyPhase 3MS (type not specified)2015-002820-20

What it found

Stopped

The trial ended early for another reason (see below).

What it measured

Main measures

  • Residual urine, measured within 10 minutes after a voluntary void at t=0 and t=6 weeks.

    Bladder, bowel and sexual function

Other measures (1)

  • - Quality of life (questionnaire: Qualiveen) at t=0 and t=6 weeks.

    Quality of life (reported by participants)

Who could take part

MS (type not specified)

Show the full criteria

Inclusion criteria

Inclusion: - Female Exclusion: - Dependency of wheel chair

Exclusion criteria

Not separately supplied in the registry.

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

Improves the alpha blocker Silodosin the bladder emptying in patients with MS?

Loading reviews and guidelines…

History

    1. Started

      Jan 2016

    Assembled by software from public sources.